0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antithrombogenic Heparin Coating Market Research Report 2026
Published Date: 2026-01-20
|
Report Code: QYRE-Auto-19L18828
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Antithrombogenic Heparin Coating Market Research Report 2024
BUY CHAPTERS

Global Antithrombogenic Heparin Coating Market Research Report 2026

Code: QYRE-Auto-19L18828
Report
2026-01-20
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Antithrombogenic Heparin Coating Market Size

The global Antithrombogenic Heparin Coating market was valued at US$ 167 million in 2025 and is anticipated to reach US$ 306 million by 2032, at a CAGR of 9.2% from 2026 to 2032.

Antithrombogenic Heparin Coating Market

Antithrombogenic Heparin Coating Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Antithrombogenic Heparin Coating competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Antithrombogenic heparin coating refers to a layer of heparin that is applied to the surface of medical devices. Heparin is a glycosaminoglycan with a high negative charge density. It is a natural anticoagulant substance that can prevent blood from clotting. The heparin used in coatings usually has a certain purity and molecular weight range to ensure its anticoagulant effect.
The North American market for Antithrombogenic Heparin Coating is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Antithrombogenic Heparin Coating is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Antithrombogenic Heparin Coating include Carmeda AB (Gore), Biointeractions, Medtronic, Surmodics, Corline, Toyobo, jMedtech, Biosurf, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Antithrombogenic Heparin Coating market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Antithrombogenic Heparin Coating. The Antithrombogenic Heparin Coating market size, estimates, and forecasts are provided in terms of sales volume (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Antithrombogenic Heparin Coating market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Antithrombogenic Heparin Coating manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Antithrombogenic Heparin Coating Market Report

Report Metric Details
Report Name Antithrombogenic Heparin Coating Market
Accounted market size in 2025 US$ 167 in million
Forecasted market size in 2032 US$ 306 million
CAGR 9.2%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Covalently Bonded Coatings
  • Physisorption Coatings
by Application
  • Catheters
  • Stents
  • Implants
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Carmeda AB (Gore), Biointeractions, Medtronic, Surmodics, Corline, Toyobo, jMedtech, Biosurf
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Antithrombogenic Heparin Coating manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Antithrombogenic Heparin Coating sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Antithrombogenic Heparin Coating Market growing?

Ans: The Antithrombogenic Heparin Coating Market witnessing a CAGR of 9.2% during the forecast period 2026-2032.

What is the Antithrombogenic Heparin Coating Market size in 2032?

Ans: The Antithrombogenic Heparin Coating Market size in 2032 will be US$ 306 million.

Who are the main players in the Antithrombogenic Heparin Coating Market report?

Ans: The main players in the Antithrombogenic Heparin Coating Market are Carmeda AB (Gore), Biointeractions, Medtronic, Surmodics, Corline, Toyobo, jMedtech, Biosurf

What are the Application segmentation covered in the Antithrombogenic Heparin Coating Market report?

Ans: The Applications covered in the Antithrombogenic Heparin Coating Market report are Catheters, Stents, Implants, Others

What are the Type segmentation covered in the Antithrombogenic Heparin Coating Market report?

Ans: The Types covered in the Antithrombogenic Heparin Coating Market report are Covalently Bonded Coatings, Physisorption Coatings

1 Antithrombogenic Heparin Coating Market Overview
1.1 Product Definition
1.2 Antithrombogenic Heparin Coating by Type
1.2.1 Global Antithrombogenic Heparin Coating Market Value by Type: 2025 vs 2032
1.2.2 Covalently Bonded Coatings
1.2.3 Physisorption Coatings
1.3 Antithrombogenic Heparin Coating by Application
1.3.1 Global Antithrombogenic Heparin Coating Market Value by Application: 2025 vs 2032
1.3.2 Catheters
1.3.3 Stents
1.3.4 Implants
1.3.5 Others
1.4 Global Antithrombogenic Heparin Coating Market Size Estimates and Forecasts
1.4.1 Global Antithrombogenic Heparin Coating Revenue 2021–2032
1.4.2 Global Antithrombogenic Heparin Coating Sales 2021–2032
1.4.3 Global Antithrombogenic Heparin Coating Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Antithrombogenic Heparin Coating Market Competition by Manufacturers
2.1 Global Antithrombogenic Heparin Coating Sales Market Share by Manufacturers (2021–2026)
2.2 Global Antithrombogenic Heparin Coating Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Antithrombogenic Heparin Coating Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Antithrombogenic Heparin Coating, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Antithrombogenic Heparin Coating, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Antithrombogenic Heparin Coating, Product Types and Applications
2.7 Global Key Manufacturers of Antithrombogenic Heparin Coating, Date of Entry into the Industry
2.8 Global Antithrombogenic Heparin Coating Market Competitive Situation and Trends
2.8.1 Global Antithrombogenic Heparin Coating Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Antithrombogenic Heparin Coating Players Market Share by Revenue
2.8.3 Global Antithrombogenic Heparin Coating Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Antithrombogenic Heparin Coating Market Scenario by Region
3.1 Global Antithrombogenic Heparin Coating Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Antithrombogenic Heparin Coating Sales by Region: 2021–2032
3.2.1 Global Antithrombogenic Heparin Coating Sales by Region: 2021–2026
3.2.2 Global Antithrombogenic Heparin Coating Sales by Region: 2027–2032
3.3 Global Antithrombogenic Heparin Coating Revenue by Region: 2021–2032
3.3.1 Global Antithrombogenic Heparin Coating Revenue by Region: 2021–2026
3.3.2 Global Antithrombogenic Heparin Coating Revenue by Region: 2027–2032
3.4 North America Antithrombogenic Heparin Coating Market Facts & Figures by Country
3.4.1 North America Antithrombogenic Heparin Coating Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Antithrombogenic Heparin Coating Sales by Country (2021–2032)
3.4.3 North America Antithrombogenic Heparin Coating Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Antithrombogenic Heparin Coating Market Facts & Figures by Country
3.5.1 Europe Antithrombogenic Heparin Coating Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Antithrombogenic Heparin Coating Sales by Country (2021–2032)
3.5.3 Europe Antithrombogenic Heparin Coating Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antithrombogenic Heparin Coating Market Facts & Figures by Region
3.6.1 Asia Pacific Antithrombogenic Heparin Coating Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Antithrombogenic Heparin Coating Sales by Region (2021–2032)
3.6.3 Asia Pacific Antithrombogenic Heparin Coating Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Antithrombogenic Heparin Coating Market Facts & Figures by Country
3.7.1 Latin America Antithrombogenic Heparin Coating Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Antithrombogenic Heparin Coating Sales by Country (2021–2032)
3.7.3 Latin America Antithrombogenic Heparin Coating Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Antithrombogenic Heparin Coating Market Facts & Figures by Country
3.8.1 Middle East and Africa Antithrombogenic Heparin Coating Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Antithrombogenic Heparin Coating Sales by Country (2021–2032)
3.8.3 Middle East and Africa Antithrombogenic Heparin Coating Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antithrombogenic Heparin Coating Sales by Type (2021–2032)
4.1.1 Global Antithrombogenic Heparin Coating Sales by Type (2021–2026)
4.1.2 Global Antithrombogenic Heparin Coating Sales by Type (2027–2032)
4.1.3 Global Antithrombogenic Heparin Coating Sales Market Share by Type (2021–2032)
4.2 Global Antithrombogenic Heparin Coating Revenue by Type (2021–2032)
4.2.1 Global Antithrombogenic Heparin Coating Revenue by Type (2021–2026)
4.2.2 Global Antithrombogenic Heparin Coating Revenue by Type (2027–2032)
4.2.3 Global Antithrombogenic Heparin Coating Revenue Market Share by Type (2021–2032)
4.3 Global Antithrombogenic Heparin Coating Price by Type (2021–2032)
5 Segment by Application
5.1 Global Antithrombogenic Heparin Coating Sales by Application (2021–2032)
5.1.1 Global Antithrombogenic Heparin Coating Sales by Application (2021–2026)
5.1.2 Global Antithrombogenic Heparin Coating Sales by Application (2027–2032)
5.1.3 Global Antithrombogenic Heparin Coating Sales Market Share by Application (2021–2032)
5.2 Global Antithrombogenic Heparin Coating Revenue by Application (2021–2032)
5.2.1 Global Antithrombogenic Heparin Coating Revenue by Application (2021–2026)
5.2.2 Global Antithrombogenic Heparin Coating Revenue by Application (2027–2032)
5.2.3 Global Antithrombogenic Heparin Coating Revenue Market Share by Application (2021–2032)
5.3 Global Antithrombogenic Heparin Coating Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Carmeda AB (Gore)
6.1.1 Carmeda AB (Gore) Company Information
6.1.2 Carmeda AB (Gore) Description and Business Overview
6.1.3 Carmeda AB (Gore) Antithrombogenic Heparin Coating Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Carmeda AB (Gore) Antithrombogenic Heparin Coating Product Portfolio
6.1.5 Carmeda AB (Gore) Recent Developments/Updates
6.2 Biointeractions
6.2.1 Biointeractions Company Information
6.2.2 Biointeractions Description and Business Overview
6.2.3 Biointeractions Antithrombogenic Heparin Coating Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Biointeractions Antithrombogenic Heparin Coating Product Portfolio
6.2.5 Biointeractions Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Company Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Antithrombogenic Heparin Coating Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Medtronic Antithrombogenic Heparin Coating Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Surmodics
6.4.1 Surmodics Company Information
6.4.2 Surmodics Description and Business Overview
6.4.3 Surmodics Antithrombogenic Heparin Coating Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Surmodics Antithrombogenic Heparin Coating Product Portfolio
6.4.5 Surmodics Recent Developments/Updates
6.5 Corline
6.5.1 Corline Company Information
6.5.2 Corline Description and Business Overview
6.5.3 Corline Antithrombogenic Heparin Coating Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Corline Antithrombogenic Heparin Coating Product Portfolio
6.5.5 Corline Recent Developments/Updates
6.6 Toyobo
6.6.1 Toyobo Company Information
6.6.2 Toyobo Description and Business Overview
6.6.3 Toyobo Antithrombogenic Heparin Coating Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Toyobo Antithrombogenic Heparin Coating Product Portfolio
6.6.5 Toyobo Recent Developments/Updates
6.7 jMedtech
6.7.1 jMedtech Company Information
6.7.2 jMedtech Description and Business Overview
6.7.3 jMedtech Antithrombogenic Heparin Coating Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 jMedtech Antithrombogenic Heparin Coating Product Portfolio
6.7.5 jMedtech Recent Developments/Updates
6.8 Biosurf
6.8.1 Biosurf Company Information
6.8.2 Biosurf Description and Business Overview
6.8.3 Biosurf Antithrombogenic Heparin Coating Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Biosurf Antithrombogenic Heparin Coating Product Portfolio
6.8.5 Biosurf Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antithrombogenic Heparin Coating Industry Chain Analysis
7.2 Antithrombogenic Heparin Coating Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antithrombogenic Heparin Coating Production Mode & Process Analysis
7.4 Antithrombogenic Heparin Coating Sales and Marketing
7.4.1 Antithrombogenic Heparin Coating Sales Channels
7.4.2 Antithrombogenic Heparin Coating Distributors
7.5 Antithrombogenic Heparin Coating Customer Analysis
8 Antithrombogenic Heparin Coating Market Dynamics
8.1 Antithrombogenic Heparin Coating Industry Trends
8.2 Antithrombogenic Heparin Coating Market Drivers
8.3 Antithrombogenic Heparin Coating Market Challenges
8.4 Antithrombogenic Heparin Coating Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Antithrombogenic Heparin Coating Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Antithrombogenic Heparin Coating Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Antithrombogenic Heparin Coating Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Antithrombogenic Heparin Coating Sales (Tons) of Key Manufacturers (2021–2026)
 Table 5. Global Antithrombogenic Heparin Coating Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Antithrombogenic Heparin Coating Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Antithrombogenic Heparin Coating Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Antithrombogenic Heparin Coating Average Price (US$/Kg) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Antithrombogenic Heparin Coating, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Antithrombogenic Heparin Coating, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Antithrombogenic Heparin Coating, Product Types and Applications
 Table 12. Global Key Manufacturers of Antithrombogenic Heparin Coating, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Antithrombogenic Heparin Coating Companies by Tier (Tier 1, Tier 2, Tier 3), based on Antithrombogenic Heparin Coating Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Antithrombogenic Heparin Coating Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Antithrombogenic Heparin Coating Sales by Region (Tons), 2021–2026
 Table 18. Global Antithrombogenic Heparin Coating Sales Market Share by Region (2021–2026)
 Table 19. Global Antithrombogenic Heparin Coating Sales by Region (Tons), 2027–2032
 Table 20. Global Antithrombogenic Heparin Coating Sales Market Share by Region (2027–2032)
 Table 21. Global Antithrombogenic Heparin Coating Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Antithrombogenic Heparin Coating Revenue Market Share by Region (2021–2026)
 Table 23. Global Antithrombogenic Heparin Coating Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Antithrombogenic Heparin Coating Revenue Market Share by Region (2027–2032)
 Table 25. North America Antithrombogenic Heparin Coating Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Antithrombogenic Heparin Coating Sales by Country (Tons), 2021–2026
 Table 27. North America Antithrombogenic Heparin Coating Sales by Country (Tons), 2027–2032
 Table 28. North America Antithrombogenic Heparin Coating Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Antithrombogenic Heparin Coating Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Antithrombogenic Heparin Coating Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Antithrombogenic Heparin Coating Sales by Country (Tons), 2021–2026
 Table 32. Europe Antithrombogenic Heparin Coating Sales by Country (Tons), 2027–2032
 Table 33. Europe Antithrombogenic Heparin Coating Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Antithrombogenic Heparin Coating Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Antithrombogenic Heparin Coating Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Antithrombogenic Heparin Coating Sales by Region (Tons), 2021–2026
 Table 37. Asia Pacific Antithrombogenic Heparin Coating Sales by Region (Tons), 2027–2032
 Table 38. Asia Pacific Antithrombogenic Heparin Coating Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Antithrombogenic Heparin Coating Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Antithrombogenic Heparin Coating Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Antithrombogenic Heparin Coating Sales by Country (Tons), 2021–2026
 Table 42. Latin America Antithrombogenic Heparin Coating Sales by Country (Tons), 2027–2032
 Table 43. Latin America Antithrombogenic Heparin Coating Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Antithrombogenic Heparin Coating Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Antithrombogenic Heparin Coating Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Antithrombogenic Heparin Coating Sales by Country (Tons), 2021–2026
 Table 47. Middle East and Africa Antithrombogenic Heparin Coating Sales by Country (Tons), 2027–2032
 Table 48. Middle East and Africa Antithrombogenic Heparin Coating Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Antithrombogenic Heparin Coating Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Antithrombogenic Heparin Coating Sales (Tons) by Type (2021–2026)
 Table 51. Global Antithrombogenic Heparin Coating Sales (Tons) by Type (2027–2032)
 Table 52. Global Antithrombogenic Heparin Coating Sales Market Share by Type (2021–2026)
 Table 53. Global Antithrombogenic Heparin Coating Sales Market Share by Type (2027–2032)
 Table 54. Global Antithrombogenic Heparin Coating Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Antithrombogenic Heparin Coating Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Antithrombogenic Heparin Coating Revenue Market Share by Type (2021–2026)
 Table 57. Global Antithrombogenic Heparin Coating Revenue Market Share by Type (2027–2032)
 Table 58. Global Antithrombogenic Heparin Coating Price (US$/Kg) by Type (2021–2026)
 Table 59. Global Antithrombogenic Heparin Coating Price (US$/Kg) by Type (2027–2032)
 Table 60. Global Antithrombogenic Heparin Coating Sales (Tons) by Application (2021–2026)
 Table 61. Global Antithrombogenic Heparin Coating Sales (Tons) by Application (2027–2032)
 Table 62. Global Antithrombogenic Heparin Coating Sales Market Share by Application (2021–2026)
 Table 63. Global Antithrombogenic Heparin Coating Sales Market Share by Application (2027–2032)
 Table 64. Global Antithrombogenic Heparin Coating Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Antithrombogenic Heparin Coating Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Antithrombogenic Heparin Coating Revenue Market Share by Application (2021–2026)
 Table 67. Global Antithrombogenic Heparin Coating Revenue Market Share by Application (2027–2032)
 Table 68. Global Antithrombogenic Heparin Coating Price (US$/Kg) by Application (2021–2026)
 Table 69. Global Antithrombogenic Heparin Coating Price (US$/Kg) by Application (2027–2032)
 Table 70. Carmeda AB (Gore) Company Information
 Table 71. Carmeda AB (Gore) Description and Business Overview
 Table 72. Carmeda AB (Gore) Antithrombogenic Heparin Coating Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 73. Carmeda AB (Gore) Antithrombogenic Heparin Coating Product
 Table 74. Carmeda AB (Gore) Recent Developments/Updates
 Table 75. Biointeractions Company Information
 Table 76. Biointeractions Description and Business Overview
 Table 77. Biointeractions Antithrombogenic Heparin Coating Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 78. Biointeractions Antithrombogenic Heparin Coating Product
 Table 79. Biointeractions Recent Developments/Updates
 Table 80. Medtronic Company Information
 Table 81. Medtronic Description and Business Overview
 Table 82. Medtronic Antithrombogenic Heparin Coating Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 83. Medtronic Antithrombogenic Heparin Coating Product
 Table 84. Medtronic Recent Developments/Updates
 Table 85. Surmodics Company Information
 Table 86. Surmodics Description and Business Overview
 Table 87. Surmodics Antithrombogenic Heparin Coating Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 88. Surmodics Antithrombogenic Heparin Coating Product
 Table 89. Surmodics Recent Developments/Updates
 Table 90. Corline Company Information
 Table 91. Corline Description and Business Overview
 Table 92. Corline Antithrombogenic Heparin Coating Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 93. Corline Antithrombogenic Heparin Coating Product
 Table 94. Corline Recent Developments/Updates
 Table 95. Toyobo Company Information
 Table 96. Toyobo Description and Business Overview
 Table 97. Toyobo Antithrombogenic Heparin Coating Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 98. Toyobo Antithrombogenic Heparin Coating Product
 Table 99. Toyobo Recent Developments/Updates
 Table 100. jMedtech Company Information
 Table 101. jMedtech Description and Business Overview
 Table 102. jMedtech Antithrombogenic Heparin Coating Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 103. jMedtech Antithrombogenic Heparin Coating Product
 Table 104. jMedtech Recent Developments/Updates
 Table 105. Biosurf Company Information
 Table 106. Biosurf Description and Business Overview
 Table 107. Biosurf Antithrombogenic Heparin Coating Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
 Table 108. Biosurf Antithrombogenic Heparin Coating Product
 Table 109. Biosurf Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Antithrombogenic Heparin Coating Distributors List
 Table 113. Antithrombogenic Heparin Coating Customers List
 Table 114. Antithrombogenic Heparin Coating Market Trends
 Table 115. Antithrombogenic Heparin Coating Market Drivers
 Table 116. Antithrombogenic Heparin Coating Market Challenges
 Table 117. Antithrombogenic Heparin Coating Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Antithrombogenic Heparin Coating
 Figure 2. Global Antithrombogenic Heparin Coating Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Antithrombogenic Heparin Coating Market Share by Type: 2025 & 2032
 Figure 4. Covalently Bonded Coatings Product Picture
 Figure 5. Physisorption Coatings Product Picture
 Figure 6. Global Antithrombogenic Heparin Coating Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Antithrombogenic Heparin Coating Market Share by Application: 2025 & 2032
 Figure 8. Catheters
 Figure 9. Stents
 Figure 10. Implants
 Figure 11. Others
 Figure 12. Global Antithrombogenic Heparin Coating Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Antithrombogenic Heparin Coating Market Size (US$ Million), 2021–2032
 Figure 14. Global Antithrombogenic Heparin Coating Sales (Tons), 2021–2032
 Figure 15. Global Antithrombogenic Heparin Coating Average Price (US$/Kg), 2021–2032
 Figure 16. Antithrombogenic Heparin Coating Report Years Considered
 Figure 17. Antithrombogenic Heparin Coating Sales Share by Manufacturers in 2025
 Figure 18. Global Antithrombogenic Heparin Coating Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Antithrombogenic Heparin Coating Players: Market Share by Revenue in Antithrombogenic Heparin Coating in 2025
 Figure 20. Antithrombogenic Heparin Coating Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Antithrombogenic Heparin Coating Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Antithrombogenic Heparin Coating Sales Market Share by Country (2021–2032)
 Figure 23. North America Antithrombogenic Heparin Coating Revenue Market Share by Country (2021–2032)
 Figure 24. United States Antithrombogenic Heparin Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Antithrombogenic Heparin Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Antithrombogenic Heparin Coating Sales Market Share by Country (2021–2032)
 Figure 27. Europe Antithrombogenic Heparin Coating Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Antithrombogenic Heparin Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Antithrombogenic Heparin Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Antithrombogenic Heparin Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Antithrombogenic Heparin Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Antithrombogenic Heparin Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Antithrombogenic Heparin Coating Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Antithrombogenic Heparin Coating Revenue Market Share by Region (2021–2032)
 Figure 35. China Antithrombogenic Heparin Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Antithrombogenic Heparin Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Antithrombogenic Heparin Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Antithrombogenic Heparin Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Antithrombogenic Heparin Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Antithrombogenic Heparin Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia Antithrombogenic Heparin Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America Antithrombogenic Heparin Coating Sales Market Share by Country (2021–2032)
 Figure 43. Latin America Antithrombogenic Heparin Coating Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico Antithrombogenic Heparin Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil Antithrombogenic Heparin Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina Antithrombogenic Heparin Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Colombia Antithrombogenic Heparin Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Antithrombogenic Heparin Coating Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Antithrombogenic Heparin Coating Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Antithrombogenic Heparin Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Antithrombogenic Heparin Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Antithrombogenic Heparin Coating Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Antithrombogenic Heparin Coating by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Antithrombogenic Heparin Coating by Type (2021–2032)
 Figure 55. Global Antithrombogenic Heparin Coating Price (US$/Kg) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Antithrombogenic Heparin Coating by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Antithrombogenic Heparin Coating by Application (2021–2032)
 Figure 58. Global Antithrombogenic Heparin Coating Price (US$/Kg) by Application (2021–2032)
 Figure 59. Antithrombogenic Heparin Coating Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI